Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson
Mallinckrodt
AstraZeneca
Moodys
McKinsey

Last Updated: October 20, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Afamelanotide

See Plans and Pricing

« Back to Dashboard

Development status for investigational drug Afamelanotide: Patents, clinical trial progress, indications

Afamelanotide is an investigational drug.

There have been 10 clinical trials for Afamelanotide. The most recent clinical trial was a Phase 3 trial, which was initiated on May 1st 2007.

The most common disease conditions in clinical trials are Protoporphyria, Erythropoietic, Vitiligo, and Keratosis, Actinic. The leading clinical trial sponsors are Clinuvel Pharmaceuticals Limited and [disabled in preview].

Recent Clinical Trials for Afamelanotide
TitleSponsorPhase
Phase III Confirmatory Study in Erythropoietic ProtoporphyriaClinuvel Pharmaceuticals LimitedPhase 3
Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Light in the Treatment of Nonsegmental VitiligoClinuvel Pharmaceuticals LimitedPhase 2
Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Light in the Treatment of Nonsegmental Vitiligo (NSV)Clinuvel Pharmaceuticals LimitedPhase 1

See all Afamelanotide clinical trials

Clinical Trial Summary for Afamelanotide

Top disease conditions for Afamelanotide
Top clinical trial sponsors for Afamelanotide

See all Afamelanotide clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKesson
Dow
Baxter
Medtronic
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.